MITOXANTRONE - A NEW ANTICANCER DRUG WITH SIGNIFICANT CLINICAL ACTIVITY

被引:267
作者
SHENKENBERG, TD
VONHOFF, DD
机构
关键词
D O I
10.7326/0003-4819-105-1-67
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:67 / 81
页数:15
相关论文
共 180 条
[1]  
AAPRO M S, 1983, Investigational New Drugs, V1, P341
[2]  
AAPRO MS, 1984, INVEST NEW DRUG, V2, P329
[3]  
ALBERTS DS, 1985, SEMIN ONCOL, V12, P38
[4]  
ALBERTS DS, 1985, CANCER TREAT REP, V69, P1321
[5]  
ALBERTS DS, 1985, INVEST NEW DRUG, V3, P101
[6]  
ALBERTS DS, 1985, CANCER RES, V45, P1879
[7]  
ALBERTS DS, 1985, INVEST NEW DRUG, V3, P81
[8]  
ALBERTS DS, 1982, P AM ASSOC CANC RES, V23, P125
[9]   PHASE-I CLINICAL-TRIAL OF MITOXANTRONE - A NEW ANTHRACENEDIONE ANTI-CANCER DRUG [J].
ALBERTS, DS ;
GRIFFITH, KS ;
GOODMAN, GE ;
HERMAN, TS ;
MURRAY, E .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1980, 5 (01) :11-15
[10]  
ALLEGRA JC, 1985, INVEST NEW DRUG, V3, P153